Opening of Medical Device Competence Center in the U.S.
Highly specialized application technology services to reduce project risk.
North American medical device companies can now fully leverage the highly specialized application technology services of Evonik to reduce project risk during the development, processing, analysis and scale-up of their bioresorbable implants.
Earlier this month, Evonik announced the opening of the Medical Device Competence Center (MDCC) near Birmingham in the U.S. State of Alabama. Joining other established application labs in Shanghai, China and Darmstadt, Germany, the MDCC boasts a strong technical team with deep industry expertise and advanced processing technologies.
In addition to established technologies such as precision extrusion and injection molding, the MDCC utilizes advanced processing technologies such as 3D printing and electrospinning to create prototypes and rapidly evaluate material properties.
The MDCC also offers highly specialized services to develop, synthesize, characterize, fabricate, analyze or customize innovative biomaterial products for use with target applications.